Related Experiment Video
Updated: Aug 24, 2025

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug
Published on: May 17, 2024
Lactobacillus group and arterial hypertension: A broad review on effects and proposed mechanisms
Danilo Duarte de Assis Gadelha1, José Luiz de Brito Alves1, Paulo César Trindade da Costa1
1Health Sciences Center, Federal University of Paraíba, João Pessoa, PB, Brazil.
Abstract:
Hypertension is the leading risk factor for cardiovascular diseases and is associated with intestinal dysbiosis with a decrease in beneficial microbiota. Probiotics can positively modulate the impaired microbiota and impart benefits to the cardiovascular system. Among them, the emended Lactobacillus has stood out as a microorganism capable of reducing blood pressure, being the target of several studies focused on managing hypertension. This review aimed to present the potential of Lactobacillus as an antihypertensive non-pharmacological strategy. We will address preclinical and clinical studies that support this proposal and the mechanisms of action by which these microorganisms reduce blood pressure or prevent its elevation.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension and Regulation of Blood Pressure
Antihypertensive Drugs: Angiotensin II Receptor Blockers
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Atherosclerosis III: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications

